HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Completed · Phase 3

Conditions studied: Paroxysmal Atrial Fibrillation

In brief

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.

Key facts

Study ID
NCT01456000
Run by
CardioFocus
People needed
405
Starts
2012-01-01
Expected to finish
2016-01-01
Last updated by the study team
2016-09-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.